Share Prices & Company Research

Market News

28 Aug 2018 | 09:17

Eco Animal Health Group receives regulatory nod to market antimicrobial treatment in Vietnam

Eco Animal Health Group said Tuesday its subsidiary ECO Animal Health Limited had received approval from Vietnam regulators to market the use of an antimicrobial treatment in pigs and poultry.

Aivlosin, ECO’s patented antimicrobial, is used for the treatment of a variety of economically important respiratory and enteric (gut) diseases in pigs and poultry.

This authorisation would allow Eco to start selling Aivlosin in Vietnam for the medication of drinking water for the treatment and prevention of porcine proliferative enteropathy in pigs; the treatment and prevention of respiratory disease associated with Mycoplasma gallisepticum in chickens and the treatment of respiratory disease in turkeys associated with Ornithobacterium rhinotracheale.

This license would also allow ECO to submit the EU approved Aivlosin regulatory files for the treatment of layers in Vietnam, the fourth largest egg producing country in Southeast Asia. 'We are extremely pleased to receive this marketing authorisation for Aivlosin in Vietnam which is the largest pork producing country in Southeast Asia and look forward to receiving an approval for commercial layers in the future,' said Peter Lawrence, Chairman of ECO.

At 9:17am: (LON:EAH) Eco Animal Health Group PLC share price was 0p at 505p

Story provided by StockMarketWire.com
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.